Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 21, 2014; 20(39): 14246-14254
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14246
Laparoscopic pancreatectomy: Indications and outcomes
Shuyin Liang, Usmaan Hameed, Shiva Jayaraman
Shuyin Liang, Usmaan Hameed, Shiva Jayaraman, Division of General Surgery, University of Toronto, Toronto, ON M6R1B5, Canada
Shiva Jayaraman, Division of General Surgery, HPB Service, St. Joseph’s Health Centre Toronto, Toronto, ON M6R1B5, Canada
Author contributions: All authors contributed to the manuscript.
Correspondence to: Shiva Jayaraman, MD, MESc, FRCSC, Division of General Surgery, HPB Service St. Joseph’s Health Centre Toronto, 30 the Queensway, SSW 221 Toronto, ON M6R1B5, Canada. jayars@stjoe.on.ca
Telephone: +1-416-530-6653 Fax: +1-416-530-6653
Received: January 20, 2014
Revised: March 23, 2014
Accepted: May 19, 2014
Published online: October 21, 2014
Abstract

The application of minimally invasive approaches to pancreatic resection for benign and malignant diseases has been growing in the last two decades. Studies have demonstrated that laparoscopic distal pancreatectomy (LDP) is feasible and safe, and many of them show that compared to open distal pancreatectomy, LDP has decreased blood loss and length of hospital stay, and equivalent post-operative complication rates and short-term oncologic outcomes. LDP is becoming the procedure of choice for benign or small low-grade malignant lesions in the distal pancreas. Minimally invasive pancreaticoduodenectomy (MIPD) has not yet been widely adopted. There is no clear evidence in favor of MIPD over open pancreaticoduodenectomy in operative time, blood loss, length of stay or rate of complications. Robotic surgery has recently been applied to pancreatectomy, and many of the advantages of laparoscopy over open surgery have been observed in robotic surgery. Laparoscopic enucleation is considered safe for patients with small, benign or low-grade malignant lesions of the pancreas that is amenable to parenchyma-preserving procedure. As surgeons’ experience with advanced laparoscopic and robotic skills has been growing around the world, new innovations and breakthrough in minimally invasive pancreatic procedures will evolve.

Keywords: Laparoscopy, Distal pancreatectomy, Pancreaticoduodenectomy, Robotic pancreatectomy, Enucleation

Core tip: This review discusses recent advances in laparoscopic distal pancreatectomy (LDP), minimally invasive pancreaticoduodenectomy (MIPD), and enucleation. Recent studies show that LDP have improved perioperative recovery and equivalent oncologic outcomes. Studies on MIPD demonstrate that it is safe in terms of intra-operative outcomes, post-operative recovery and early oncologic outcomes; however, it requires advanced laparoscopic skills. Laparoscopic enucleation has become the operation of choice for small benign tumours that are away from the main pancreatic duct, especially insulinomas. We also summarize key results in pre-operative, perioperative and post-operative outcomes from contemporary series comparing open and laparoscopic pancreatic resections in the tables.